Passa al contenuto
Merck

Directed differentiation of human pluripotent cells to neural crest stem cells.

Nature protocols (2013-01-05)
Laura Menendez, Michael J Kulik, Austin T Page, Sarah S Park, James D Lauderdale, Michael L Cunningham, Stephen Dalton
ABSTRACT

Multipotent neural crest stem cells (NCSCs) have the potential to generate a wide range of cell types including melanocytes; peripheral neurons; and smooth muscle, bone, cartilage and fat cells. This protocol describes in detail how to perform a highly efficient, lineage-specific differentiation of human pluripotent cells to a NCSC fate. The approach uses chemically defined media under feeder-free conditions, and it uses two small-molecule compounds to achieve efficient conversion of human pluripotent cells to NCSCs in ~15 d. After completion of this protocol, NCSCs can be used for numerous applications, including the generation of sufficient cell numbers to perform drug screens, for the development of cell therapeutics on an industrial scale and to provide a robust model for human disease. This protocol can be also be applied to patient-derived induced pluripotent stem cells and thus used to further the knowledge of human disease associated with neural crest development, for example, Treacher-Collins Syndrome.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Laminina, 1-2 mg/mL in Tris-buffered saline, 0.2 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Proteasi, Type XIV, ≥3.5 units/mg solid, powder
Sigma-Aldrich
N6,2′-O-Dibutirril-adenosina 3′,5′-ciclica monofosfato, ≥97% (HPLC), powder
Sigma-Aldrich
Monoclonal Anti-β-Tubulin III antibody produced in mouse, clone SDL.3D10, ascites fluid
Sigma-Aldrich
Anticorpo anti-periferina, serum, Chemicon®
Sigma-Aldrich
GSK-3 Inhibitor IX, BIO, CAS 667463-62-9, is a cell-permeable, highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α/β (IC₅₀ = 5 nM). Maintains self-renewal in human & mouse embryonic stem cells.
Sigma-Aldrich
Anti-HNK-1/N-CAM (CD57) antibody, Mouse monoclonal, clone VC1.1, purified from hybridoma cell culture
Sigma-Aldrich
N-Acetyl-Lys-Pro-Arg-7-amido-4-trifluoromethylcoumarin, ≥95% (HPLC), solid